UK MHRA Will Not Implement Stricter Review For Existing Male Valproate Patients

 
• By Eliza Slawther
  
Valproate has been linked with an increased risk of neurodevelopmental disorders in children fathered by men taking the drug (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet